Cargando…
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis
PURPOSE: The aim of this study was to find clinically relevant MIBG-avid metastatic patterns in patients with newly diagnosed stage 4 neuroblastoma. METHODS: Diagnostic (123)I-MIBG scans from 249 patients (123 from a European and 126 from the COG cohort) were assessed for metastatic spread in 14 bod...
Autores principales: | Bleeker, Gitta, van Eck-Smit, Berthe L., Zwinderman, Koos H., Versteeg, Rogier, van Noesel, Max M., Kam, Boen L., Kaspers, Gertjan J., van Schie, Annelies, Kreissman, Susan G., Yanik, Gregory, Hero, Barbara, Schmidt, Matthias, Laureys, Geneviève, Lambert, Bieke, Øra, Ingrid, Schulte, Johannes H., Caron, Huib N., Tytgat, Godelieve A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315489/ https://www.ncbi.nlm.nih.gov/pubmed/25267348 http://dx.doi.org/10.1007/s00259-014-2909-1 |
Ejemplares similares
-
The role of (131)I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
por: Schoot, Reineke A., et al.
Publicado: (2013) -
Toxicity of upfront (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
por: Bleeker, Gitta, et al.
Publicado: (2013) -
123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma
por: Bleeker, Gitta, et al.
Publicado: (2015) -
MYCN and the epigenome
por: He, Stanley, et al.
Publicado: (2013) -
MYCN is amplified during S phase, and c-myb is involved in controlling MYCN expression and amplification in MYCN-amplified neuroblastoma cell lines
por: Aygun, Nevim, et al.
Publicado: (2019)